Ulixertinib (Standard)

Overview

Ulixertinib (Standard) is the analytical standard of Ulixertinib. This product is intended for research and analytical applications. Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2 . Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 ( pERK ) and downstream kinase RSK (pRSK) in an A375 melanoma cell line.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Others | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > ERK | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-15816R
• CAS No.: 869886-67-9
• Molecular Formula: C21H22Cl2N4O2
• Molecular Weight: 433.33
• Purity: 98.37%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source